DRAGARWQDr Agarwals Eye Hospital Limited
Convert to ideaThe verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeMomentum from moving averages, Supertrend and RSI.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
Forensic screen of the latest filings
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q1 FY2027 vs Q1 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q1 FY2027 | ₹143 Cr | ₹23 Cr | 22.22% | 16.35% | ₹48.38 | 11.5x |
| Q4 FY2026 | ₹120 Cr | ₹16 Cr | 18.03% | 13.52% | ₹33.60 | 11.0x |
| Q3 FY2026 | ₹116 Cr | ₹17 Cr | 19.53% | 14.87% | ₹35.76 | 11.2x |
| Q2 FY2026 | ₹118 Cr | ₹19 Cr | 24.44% | 16.41% | ₹41.04 | 7.7x |
| Q1 FY2026 | ₹117 Cr | ₹17 Cr | 22.71% | 14.76% | ₹36.72 | 6.4x |
| Q4 FY2025 | ₹100 Cr | ₹16 Cr | 21.43% | 16.02% | ₹34.02 | 7.4x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Sector
Compare with peers →Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.